Abdul-Mohaymen, N., Al-Obaidi, A. B., & Rasheed, T. (2011). High expression of P53 protein in recurrent pregnancy loss could play a role in the pathology! Journal of the Faculty of Medicine Baghdad, 53(2), 194–197.

Al-Gazally, M. E., Al-Awad, A. S., & Kzar, H. H. (2016a). Evaluating the superoxide dismutase-1 status in wild type and mutant at codons 12 and 13 of KRAS gene spectrum for the patients with sporadic colorectal cancer. International Journal of PharmTech Research, 9(3), 272–279.

Al-Gazally, M. E., Al-Awad, A. S., & Kzar, H. H. (2016b). Assessment of antioxidant status in different genotypes/phenotypes at codon 72 of TP53 gene for patients with sporadic colorectal cancer in Babylon Province. International Journal of PharmTech Research, 9(3), 280–286.

Al-Haddad, R. H., Jasim, H. M., & Saleh, W. A. (2020). Lack of association between LCS6 variant in KRAS gene with the occurrence of breast tumors in Iraqi women. Baghdad Science Journal, 17(2), 426–430.

Bisson, C., Dautel, S., Patel, E., Suresh, S., Dauer, P., & Rana, S. (2023). Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum. Frontiers in Medicine, 10, 1144170.

Bong, I., Lim, P., Balraj, P., Sim Ui Hang, E., & Zakaria, Z. (2006). Quantitative analysis of the expression of p53 gene in colorectal carcinoma by using real-time PCR. Tropical Biomedicine, 23(1), 53–59.

Burton, G. J., Redman, C. W., Roberts, J. M., & Moffett, A. (2019). Pre-eclampsia: Pathophysiology and clinical implications. British Medical Journal, 366, l2381.

Ferretti, C., Bruni, L., Dangles-Marie, V., Pecking, A. P., & Bellet, D. (2007). Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Human Reproduction Update, 13(2), 121–141.

Hamarsheh, S., Groß, O., Brummer, T., & Zeiser, R. (2020). Immune modulatory effects of oncogenic KRAS in cancer. Nature Communications, 11(1), 5439.

Ives, C. W., Sinkey, R., Rajapreyar, I., Tita, A. T. N., & Oparil, S. (2020). Preeclampsia – pathophysiology and clinical presentations: JACC state-of-the-art review. Journal of the American College of Cardiology, 76(14), 1690–1702.

Jaiswal, S. K., Raj, S., & DePamphilis, M. L. (2021). Developmental acquisition of p53 functions. Genes, 12(11), 1675.

Jancík, S., Drábek, J., Radzioch, D., & Hajdúch, M. (2010). Clinical relevance of KRAS in human cancers. Journal of Biomedicine and Biotechnology, 2010, 150960.

László, L., Kurilla, A., Takács, T., Kudlik, G., Koprivanacz, K., Buday, L., & Vas, V. (2021). Recent updates on the significance of KRAS mutations in colorectal cancer biology. Cells, 10(3), 667.

Moulder, D. E., Hatoum, D., Tay, E., Lin, Y., & McGowan, E. M. (2018). The roles of p53 in mitochondrial dynamics and cancer metabolism: The pendulum between survival and death in breast cancer? Cancers, 10(6), 189.

Olcum, M., Tufekci, K. U., & Genc, S. (2022). MicroRNAs in genetic etiology of human diseases. Methods in Molecular Biology, 2257, 255–268.

Sharp, A. N., Heazell, A. E., Baczyk, D., Dunk, C. E., Lacey, H. A., Jones, C. J., Perkins, J. E., Kingdom, J. C., Baker, P. N., & Crocker, I. P. (2014). Preeclampsia is associated with alterations in the p53-pathway in villous trophoblast. PloS One, 9(1), e87621.

Weber, S. M., & Carroll, S. L. (2021). The role of r-ras proteins in normal and pathologic migration and morphologic change. The American Journal of Pathology, 191(9), 1499–1510.

Zhao, Y., Zhao, G., & Li, W. (2022). MicroRNA-495 suppresses pre-eclampsia via activation of p53/PUMA axis. Cell Death Discovery, 8(1), 132.